Elevance Health, Inc. ELV has set its sights on expanding its suite of whole health services through the acquisition of Paragon Healthcare. Specializing in providing life-giving and life-saving injectable and infusible therapies, Paragon Healthcare’s expertise aligns seamlessly with Elevance Health’s commitment to providing low-cost specialty medications and services for members dealing with complex and chronic illnesses.
Elevance Health’s strategic move to offer services at in-home as well as ambulatory locations is set to break down barriers to care. The acquisition is expected to further drive revenues for Carelon, ELV’s health services segment, and position the company for significant growth.
As ELV continues to enhance its offerings for healthcare providers and members, the company is eyeing geographical expansion post-acquisition. By leveraging Paragon’s customer base, Elevance Health aims to fortify its position in the market, aligning with its long-term target of 12-15% adjusted earnings per share growth. The company remains steadfast in providing a simpler, affordable, and accessible healthcare experience for its customers.
Steering a Positive Trajectory
The acquisition has already borne fruits as Elevance Health’s shares gained 10.4% in the past six months, outperforming the modest 0.9% rise of the broader medical services industry.
Image Source: Zacks Investment Research
Zacks Rank & Key Market Players
Elevance Health currently holds a Zacks Rank #3 (Hold). In the broader medical space, stocks such as Atai Life Sciences N.V. (ATAI), Biodesix, Inc. (BDSX), and Cencora, Inc. (COR) present promising opportunities, each carrying a Zacks Rank #2 (Buy).
Atai Life Sciences is anticipated to witness a significant improvement in the current-year earnings. Biodesix is projected for a substantial year-over-year increase in 2023 earnings and revenues. Similarly, Cencora’s bottom line is anticipated to see healthy growth in fiscal 2024.
Looking Ahead
Elevance Health’s acquisition of Paragon Healthcare not only fortifies its whole health services but also positions the company for sustained growth. With a focus on enhancing customer experience and expanding its geographical footprint, ELV is primed for a positive trajectory in the evolving healthcare landscape.
As Elevance Health continues to navigate the complexities of the healthcare industry, the company remains committed to its mission of providing affordable, accessible, and comprehensive healthcare solutions, ultimately benefiting its providers, members, and shareholders alike.
Investors can anticipate a transformational journey for Elevance Health as it paves the way for a holistic, whole health experience that is both impactful and sustainable.
